Although the word "Proteome" also appeared in 1995 for the first time, it was hardly observed at that time. On the other hand, some papers about a microarray were released at the same time. The microarray has spread in an instant, and although there is the side in which it is troubled by the interpretation for too much a vast quantity of data, the information which transcriptomics brings about is achieving success certainly, and greatly has begun to contribute not only to drug discovery but to the life science field. Then, how is it about proteomics? Although the result has appeared in the search for a clinical marker for a serum sample without genome, there is almost no example of a success which contributed to life science in proteome analysis. In a transcriptomics and proteomics, a di#erence is in the amount of information acquired too much. The current proteomics understands only a part very much. Furthermore, proteomics is greatly inferior also in through-put. Just the information which cannot be acquired only from a gene is considered to be the directivity of future proteomics. Therefore, we should focus on protein-complex analysis, post-translational modification study etc. and then should contribute to life science by performing more practical proteomics. The key of future proteomics is pursued not only in proteomics but in all fields about high speed, quantity sensitivity, automation, and information processing. Since it has already turned into fixed form business about identification of the protein using MS, it is a point how it utilizes well in a life science field. Application of chemical design like ICAT and genetic design like TAP are expected in a technical side. And breakthroughs, such as development of a protein chip which is located in a line with a DNA chip, and an amplification means of the protein equivalent to PCR, may also appear suddenly.
1.
῎ ῌ Fig. 1 . The conceptual figure of comparison of transcriptome and proteome. Although both are comprehensive analyses, the current proteome understands only a part very much. Furthermore, proteomics is greatly inferior also in through-put.
The View of Proteomics
From classical proteome to focused proteome. It is di$cult to find low abundant proteins on a two-dimensional electrophoresis from a whole cell extracted sample. But after the enrichment of interesting target mixture, electrophoretic or chromatographic based separation is useful to identify low abundant proteins. H. Katayama and Y. Oda Although glycine also has the same tendency, glycine is not so remarkable as proline.
H. Katayama and Y. Oda H. Katayama and Y. Oda Table 2 . The Example of Identified Proteins by ICAT The position of cysteine is important. If cyteine is located at middle of a peptide, the identification of the protein is di$cult. Furthermore, bigger peptides are also di$cult to assign. C C῍SSILIHGK: Na/K-ATPase alpha subunit C C῍AADLGLNK:
Protein kinase C inhibitor 1 C C῍GPMVLDALIK:
Succinate dehydrogenase C C῍AGNEDIITLR:
Proliferating cell nuclear antigen C C῍LAPMMSEVIR:
Hydroxyacyl-Coenzyme A dehydrogenase C C῍NEPAVWSQLAK:
Clathrin heavy chain C C῍EFQDAYVLLSEK:
Heat shock 60 kD protein 1 C C῍IEWMGGVGYTK:
Acyl-Coenzyme A dehydrogenase C C῍GEEIAVQFVDMVK:
3-Phosphoglycerate dehydrogenase C C῍SSFMAPPVTDLGELR:
Coproporphyrinogen oxidase IC C῍AVGITK:
Cellular apoptosis susceptibility protein GC C῍DVVVIPAGVPR:
Malate dehydrogenase 2 VC C῍DIAAELAR:
Karyopherin beta 3 AVC C῍MLSNTTAIAEAWAR:
Tubulin, alpha 3 GIFPVLC C῍K:
Pyruvate kinase AKFENLC C῍K:
Heat shock 90 kD protein 1 STLTDSLC C῍K:
Elongation factor 2 LGPGMADIC C῍K: Prosaposin VNQIGSVTESLQAC C῍K:
Enolase alpha EATGAASGAAAGGPGAGC C῍VGL:
Hypothetical protein FLJ22477
Chemical Design TAP 2) Ge-
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Keywords: Proteomics, Mass spectrometry, In-gel digestion, Quantitative proteome, Focused proteome In vivo labeling Since it can correct recovery e$ciency in all the steps from a pretreatment to a MS analysis, precision is very high.
It can be adapted also for a site specific quantitation of post-translational modification.
There are a lot of cases where in vivo labeling, such as a man organization, are di$cult.
The use of those other than a stable isotope labeling is di$cult.
In present search engines, identification of proteins from isotope labeled peptides is di$cult.
In vitro labeling
Application is possible to all samples from culture cells to an animal organization.
Various labeling tag can be used.
Tags other than isotope can also be used.
By present seach engines, it can respond to some extent.
The di#erence in the recovery e$ciency in a pretreatment, such as subfractionation, a$nity purification, etc. cannot be corrected, because those steps are done before in vitro labeling.
Judgment may not be able to do whether it is change of expression level, and whether it is change of post-translational modification.
AS for MS data analysis, it is not simple that fragmentation is complicated and protein identification cannot be performed, that the size of peptide in which analysis is possible is restricted since the molecular weight of a tag is large again, etc.
